Abstract
Inflammatory and infectious diseases include many different clinical conditions not often well recognised and characterized with conventional radiology and biochemical tests. Radiological techniques (TC, MRI, US) show anatomical changes that usually occur in chronic stages of the disease leading to a delayed diagnosis and therapy. The possibility of Nuclear Medicine imaging to detect biological and biochemical changes in the earliest phases of diseases, allow the clinician not only to promptly identify the infective or inflammatory focus, but also to establish the best therapeutic approach for the patient. The recent availability of different monoclonal antibodies and analogues of growth and signalling factors offers physicians a wide spectrum of promising radiopharmaceuticals as markers for different pathological events. Therefore, NM may help in therapy decision making, management and follow-up through the evaluation of the expression of these specific molecules, leading to the development of personalized therapies. The appeal to Nuclear Medicine imaging is becoming, indeed, more and more widespread not only for diagnostic purposes, but also for monitoring drug efficacy. Several advances have been observed in this field, and they seem to be very promising for a tailored medicine.
Keywords: Infection, inflammation, radiolabelled cells, radiolabelled antibodies, radiolabelled antibiotics, FDG.
Current Pharmaceutical Design
Title:Radiolabelled Probes Targeting Infection and Inflammation for Personalized Medicine
Volume: 20 Issue: 14
Author(s): Alberto Signore, Chiara Lauri and Filippo Galli
Affiliation:
Keywords: Infection, inflammation, radiolabelled cells, radiolabelled antibodies, radiolabelled antibiotics, FDG.
Abstract: Inflammatory and infectious diseases include many different clinical conditions not often well recognised and characterized with conventional radiology and biochemical tests. Radiological techniques (TC, MRI, US) show anatomical changes that usually occur in chronic stages of the disease leading to a delayed diagnosis and therapy. The possibility of Nuclear Medicine imaging to detect biological and biochemical changes in the earliest phases of diseases, allow the clinician not only to promptly identify the infective or inflammatory focus, but also to establish the best therapeutic approach for the patient. The recent availability of different monoclonal antibodies and analogues of growth and signalling factors offers physicians a wide spectrum of promising radiopharmaceuticals as markers for different pathological events. Therefore, NM may help in therapy decision making, management and follow-up through the evaluation of the expression of these specific molecules, leading to the development of personalized therapies. The appeal to Nuclear Medicine imaging is becoming, indeed, more and more widespread not only for diagnostic purposes, but also for monitoring drug efficacy. Several advances have been observed in this field, and they seem to be very promising for a tailored medicine.
Export Options
About this article
Cite this article as:
Signore Alberto, Lauri Chiara and Galli Filippo, Radiolabelled Probes Targeting Infection and Inflammation for Personalized Medicine, Current Pharmaceutical Design 2014; 20 (14) . https://dx.doi.org/10.2174/13816128113196660666
DOI https://dx.doi.org/10.2174/13816128113196660666 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Characterization of a Bacteriophage-Derived Murein Peptidase for Elimination of Antibiotic-Resistant Staphylococcus aureus
Current Protein & Peptide Science Ceftriaxone-Vancomycin Drug Toxicity Reduction by VRP 1020 in Mus musculus Mice
Current Clinical Pharmacology Structure Based Virtual Screening for the Identification of Potential Inhibitors for Penicillin Binding Protein 2B of the Resistant 5204 Strain of <i>Streptococcus pneumoniae</i>
Current Bioinformatics Editorial: Bioengineering, Clinical and Therapeutical Trends in Transcatheter Aortic Valve Implantation
Current Pharmaceutical Design Ischemic Strokes in Congenital Bleeding Disorders: Comparison with Myocardial Infarction and other Acute Coronary Syndromes
Cardiovascular & Hematological Disorders-Drug Targets Association of Pharmacokinetic and Pharmacodynamic Aspects of Linezolid with Infection Outcome
Current Drug Metabolism Naturally Occurring Peptides from Rana temporaria: Antimicrobial Properties and More
Current Topics in Medicinal Chemistry Inside the Pan-genome - Methods and Software Overview
Current Genomics Systemic Inflammatory Response as a Risk and Prognosis Factor in Ventilator-Associated Pneumonia
Current Respiratory Medicine Reviews Treatment Options for Persistent Coagulase Negative Staphylococcal Bacteremia in Neonates
Current Pediatric Reviews Fluoroquinolones: Blessings Or Curses
Current Drug Targets New Imaging Tracers for the Infected Diabetic Foot (Nuclear and Optical Imaging)
Current Pharmaceutical Design Appropriate Utilization of Restricted Antibiotics in a General Hospital of a Perfecture Area in Greece
Current Drug Safety Cardiac Tumors: Clinical Perspective and Therapeutic Considerations
Current Drug Targets Allergic Bronchopulmonary Aspergillosis: AllA Radiologist Needs To Know
Current Pediatric Reviews N-Containing Ag(I) and Hg(II) Complexes: A New Class of Antibiotics
Current Topics in Medicinal Chemistry Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer
Current Pharmaceutical Design Advances in Peptide Pharmaceuticals
Current Pharmaceutical Biotechnology The Role of Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Drug Development for Ischemic Stroke: From Laboratory to Clinics
Current Vascular Pharmacology Regulating the Safety of Probiotics - The European Approach
Current Pharmaceutical Design